002734.SZ
Limin Group Co., Ltd. [002734.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002734.SZ Stock Summary
Top 10 Correlated ETFs
002734.SZ
Top 10 Correlated Stocks
002734.SZ
In the News
002734.SZ Financial details
Company Rating
Strong Buy
Market Cap
3.75B
Income
215.98M
Revenue
5.08B
Book val./share
7.34
Cash/share
4.07
Dividend
0.3
Dividend %
2.98%
Employees
4.58K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
17.41
Forward P/E
-
PEG
-3.87
P/S
0.74
P/B
1.37
P/C
2.47
P/FCF
-12.44
Quick Ratio
0.41
Current Ratio
0.91
Debt / Equity
1.86
LT Debt / Equity
0.46
-
-
EPS (TTM)
0.58
EPS next Y
-
EPS next Q
-
EPS this Y
-20.95%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
17.19%
Revenue last 5Y
27.19%
Revenue Q/Q
-21.07%
EPS Q/Q
-48.87%
-
-
-
-
SMA20
-15.22%
SMA50
4.15%
SMA100
7.16%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
8%
ROC
0.06%
Gross Margin
19%
Oper. Margin
5%
Profit Margin
4%
Payout
74%
Shs Outstand
372.56M
Shs Float
216.6M
-
-
-
-
Target Price
-
52W Range
8.76-12.96
52W High
-16.17%
52W Low
+25.75%
RSI
35.53
Rel Volume
0.39
Avg Volume
7.12M
Volume
2.76M
Perf Week
-0.49%
Perf Month
-6.59%
Perf Quarter
5.12%
Perf Half Y
2.24%
-
-
-
-
Beta
0.442241
-
-
Volatility
0.08%, 0.77%
Prev Close
0.2%
Price
10.06
Change
0%
002734.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 3.89 | 4.2 | 7.99 | 11.94 | 12.89 | |
| Net income per share | 0.38 | 0.57 | 0.91 | 1.05 | 0.83 | |
| Operating cash flow per share | 0.2 | 0.64 | 0.56 | 2.46 | 0.16 | |
| Free cash flow per share | -0.19 | 0.15 | -0.51 | 1.51 | -2.68 | |
| Cash per share | 1.05 | 0.99 | 1.26 | 1.99 | 2.97 | |
| Book value per share | 4.57 | 5.02 | 5.84 | 6.44 | 7.35 | |
| Tangible book value per share | 4.19 | 4.65 | 5.37 | 5.71 | 6.39 | |
| Share holders equity per share | 4.57 | 5.02 | 5.84 | 6.44 | 7.35 | |
| Interest debt per share | 1.03 | 1.62 | 3.06 | 3 | 6.09 | |
| Market cap | 3.7B | 2.6B | 3.53B | 4.45B | 4.68B | |
| Enterprise value | 3.68B | 2.8B | 4.12B | 4.76B | 5.88B | |
| P/E ratio | 26.97 | 12.6 | 10.95 | 11.52 | 15.23 | |
| Price to sales ratio | 2.6 | 1.71 | 1.24 | 1.01 | 0.99 | |
| POCF ratio | 50.68 | 11.21 | 17.9 | 4.92 | 78.44 | |
| PFCF ratio | -52.5 | 47.68 | -19.43 | 8.02 | -4.75 | |
| P/B Ratio | 2.21 | 1.43 | 1.7 | 1.88 | 1.73 | |
| PTB ratio | 2.21 | 1.43 | 1.7 | 1.88 | 1.73 | |
| EV to sales | 2.59 | 1.84 | 1.45 | 1.08 | 1.24 | |
| Enterprise value over EBITDA | 13.59 | 7.74 | 7.33 | 6.66 | 8.68 | |
| EV to operating cash flow | 50.37 | 12.1 | 20.89 | 5.27 | 98.59 | |
| EV to free cash flow | -52.18 | 51.44 | -22.68 | 8.59 | -5.97 | |
| Earnings yield | 0.04 | 0.08 | 0.09 | 0.09 | 0.07 | |
| Free cash flow yield | -0.02 | 0.02 | -0.05 | 0.12 | -0.21 | |
| Debt to equity | 0.39 | 0.47 | 1.19 | 1.13 | 1.48 | |
| Debt to assets | 0.27 | 0.31 | 0.52 | 0.52 | 0.58 | |
| Net debt to EBITDA | -0.08 | 0.57 | 1.05 | 0.44 | 1.77 | |
| Current ratio | 1.92 | 1.85 | 0.98 | 0.95 | 1.03 | |
| Interest coverage | 8.93 | 6.71 | 4.46 | 8.33 | 5.68 | |
| Income quality | 0.53 | 1.12 | 0.61 | 2.34 | 0.19 | |
| Dividend Yield | 0.02 | 0.04 | 0.04 | 0.03 | 0.03 | |
| Payout ratio | 0.54 | 0.49 | 0.44 | 0.36 | 0.46 | |
| Sales general and administrative to revenue | 0.03 | 0.04 | 0.04 | 0.02 | 0.02 | |
| Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | |
| Intangibles to total assets | 0.08 | 0.07 | 0.08 | 0.08 | 0.08 | |
| Capex to operating cash flow | -1.97 | -0.76 | -1.92 | -0.39 | -17.52 | |
| Capex to revenue | -0.1 | -0.12 | -0.13 | -0.08 | -0.22 | |
| Capex to depreciation | -1.47 | -1.54 | -2.22 | -1.67 | -3.93 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 6.22 | 8.02 | 10.92 | 12.34 | 11.75 | |
| ROIC | 0.09 | 0.07 | 0.06 | 0.13 | 0.08 | |
| Return on tangible assets | 0.06 | 0.08 | 0.07 | 0.08 | 0.05 | |
| Graham Net | -0.42 | -1.01 | -4.68 | -4.38 | -6.47 | |
| Working capital | 569.22M | 663.7M | -48.93M | -120.91M | 83.44M | |
| Tangible asset value | 1.53B | 1.68B | 1.91B | 2.1B | 2.35B | |
| Net current asset value | 534.48M | 583.41M | -418.81M | -494.06M | -1.07B | |
| Invested capital | 0.22 | 0.31 | 0.5 | 0.44 | 0.8 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 100.49M | 88.95M | 316.05M | 548.29M | 704.07M | |
| Average inventory | 185.54M | 252.04M | 497.37M | 694.36M | 862.33M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 32.27 | 28.8 | 95.77 | 60.99 | 85.25 | |
| Days of inventory on hand | 85.18 | 87.41 | 128.29 | 72.83 | 106.09 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 11.31 | 12.67 | 3.81 | 5.98 | 4.28 | |
| Inventory turnover | 4.29 | 4.18 | 2.85 | 5.01 | 3.44 | |
| ROE | 0.08 | 0.11 | 0.16 | 0.16 | 0.11 | |
| Capex per share | -0.39 | -0.49 | -1.07 | -0.95 | -2.84 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 3.1 | 2.77 | 3.33 | 4.18 | 3.3 | |
| Net income per share | 0.06 | 0.1 | 0.26 | 0.14 | 0.07 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | -0.57 | -0.32 | -0.94 | 0.55 | -0.09 | |
| Cash per share | 2.59 | 2.92 | 3 | 4.21 | 4.07 | |
| Book value per share | 7.27 | 7.23 | 7.49 | 7.26 | 7.34 | |
| Tangible book value per share | 6.63 | 6.29 | 6.6 | 6 | 6.1 | |
| Share holders equity per share | 7.27 | 7.23 | 7.49 | 7.26 | 7.34 | |
| Interest debt per share | 5.5 | 5.82 | 6.64 | 7.94 | 8.11 | |
| Market cap | 3.99B | 4.75B | 3.98B | 3.76B | 3.36B | |
| Enterprise value | 5.06B | 5.95B | 5.52B | 5.43B | 5.38B | |
| P/E ratio | 44.01 | 32.14 | 10.25 | 17.36 | 30.35 | |
| Price to sales ratio | 3.44 | 4.59 | 3.2 | 2.41 | 2.72 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | -18.66 | -39.92 | -11.3 | 18.28 | -95.15 | |
| P/B Ratio | 1.47 | 1.76 | 1.42 | 1.39 | 1.23 | |
| PTB ratio | 1.47 | 1.76 | 1.42 | 1.39 | 1.23 | |
| EV to sales | 4.35 | 5.75 | 4.43 | 3.48 | 4.36 | |
| Enterprise value over EBITDA | 96.85 | 275.17 | 41.75 | 61.03 | 110.6 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | -23.61 | -50.01 | -15.65 | 26.41 | -152.42 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Free cash flow yield | -0.05 | -0.03 | -0.09 | 0.05 | -0.01 | |
| Debt to equity | 1.33 | 1.48 | 1.52 | 1.82 | 1.86 | |
| Debt to assets | 0.56 | 0.58 | 0.59 | 0.64 | 0.65 | |
| Net debt to EBITDA | 20.33 | 55.49 | 11.61 | 18.79 | 41.56 | |
| Current ratio | 1.23 | 1.03 | 1.07 | 0.97 | 0.91 | |
| Interest coverage | 1.51 | 7 | 6.99 | 3.23 | 2.81 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0.03 | 0 | |
| Payout ratio | 0.67 | 0.26 | 0.18 | 2.34 | 0.18 | |
| Sales general and administrative to revenue | 0.15 | -0.11 | 0.05 | -0.02 | 0.15 | |
| Research and developement to revenue | 0.05 | 0.05 | 0.02 | 0.03 | 0.04 | |
| Intangibles to total assets | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | -0.22 | -0.41 | -0.19 | -0.1 | -0.13 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.15 | 4.01 | 6.62 | 4.86 | 3.5 | |
| ROIC | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Return on tangible assets | 0 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham Net | -6.08 | -6.37 | -7 | -7.95 | -8.48 | |
| Working capital | 544.31M | 83.44M | 208.56M | -108.73M | -321.26M | |
| Tangible asset value | 2.48B | 2.35B | 2.47B | 2.24B | 2.28B | |
| Net current asset value | -716.1M | -1.07B | -1.11B | -1.49B | -1.71B | |
| Invested capital | 0.75 | 0.8 | 0.88 | 1.09 | 1.1 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 887.43M | 883.86M | 941.43M | 1.08B | 1.17B | |
| Average inventory | 793.14M | 909.78M | 1.05B | 906.93M | 792.62M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 86.56 | 95.48 | 95.95 | 76.79 | 106.55 | |
| Days of inventory on hand | 71.6 | 118.82 | 95.87 | 53.35 | 70.14 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 1.04 | 0.94 | 0.94 | 1.17 | 0.84 | |
| Inventory turnover | 1.26 | 0.76 | 0.94 | 1.69 | 1.28 | |
| ROE | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | |
| Capex per share | -0.67 | -1.13 | -0.64 | -0.43 | -0.44 |
002734.SZ Frequently Asked Questions
What is Limin Group Co., Ltd. stock symbol ?
Limin Group Co., Ltd. is a CN stock and trading under the symbol 002734.SZ
What is Limin Group Co., Ltd. stock quote today ?
Limin Group Co., Ltd. stock price is $10.06 today.
Is Limin Group Co., Ltd. stock public?
Yes, Limin Group Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 7.12M
- Market Capitalization 3.75B
- Employee 4.58K
- CEO Mr. Chaohui Fan
- Headquarters Xinyi,CN
- IPO Date 2015-02-03
-
Website
https://www.chinalimin.com 
Limin Group Co., Ltd. researches, develops, manufactures, and markets fungicides and other pesticides in China. The company offers various pesticide technical materials and preparations, such as mancozeb, cymoxanil, fosetyl-aluminum, propineb, pyrimethanil, propiconazole, difenoconazole, chlorothalonil, thiacloprid, metham sodium, Zineb, etc. It sells its products in approximately 70 countries and regions. The company was formerly known as Limin Chemical Co., Ltd. and changed its name to Limin Group Co., Ltd. in January 2020. Limin Group Co., Ltd. is headquartered in Xinyi, China.
